Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue

Severe acute respiratory syndrome (SARS)-CoV-2 virus disease (coronavirus disease 2019; COVID-19) is associated with increased coagulation activity, resulting in an excessive risk of venous thromboembolism (VTE) and poor prognosis. The most common manifestation of VTE is pulmonary embolism (PE), wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanidas, Elias, Grassos, Charalampos, Papadopoulos, Dimitrios, Velliou, Maria, Barbetseas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114761/
https://www.ncbi.nlm.nih.gov/pubmed/34049806
http://dx.doi.org/10.1016/j.hlc.2021.04.018
_version_ 1783691113512566784
author Sanidas, Elias
Grassos, Charalampos
Papadopoulos, Dimitrios
Velliou, Maria
Barbetseas, John
author_facet Sanidas, Elias
Grassos, Charalampos
Papadopoulos, Dimitrios
Velliou, Maria
Barbetseas, John
author_sort Sanidas, Elias
collection PubMed
description Severe acute respiratory syndrome (SARS)-CoV-2 virus disease (coronavirus disease 2019; COVID-19) is associated with increased coagulation activity, resulting in an excessive risk of venous thromboembolism (VTE) and poor prognosis. The most common manifestation of VTE is pulmonary embolism (PE), with approximately one in five hospitalised patients being at risk. These reports led to the empirical use of prophylactic anticoagulation, even in the absence of established or clinically suspected disease. This review summarises current aspects and recommendations regarding the use of thromboprophylaxis for PE in patients with COVID-19.
format Online
Article
Text
id pubmed-8114761
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81147612021-05-13 Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue Sanidas, Elias Grassos, Charalampos Papadopoulos, Dimitrios Velliou, Maria Barbetseas, John Heart Lung Circ Review Severe acute respiratory syndrome (SARS)-CoV-2 virus disease (coronavirus disease 2019; COVID-19) is associated with increased coagulation activity, resulting in an excessive risk of venous thromboembolism (VTE) and poor prognosis. The most common manifestation of VTE is pulmonary embolism (PE), with approximately one in five hospitalised patients being at risk. These reports led to the empirical use of prophylactic anticoagulation, even in the absence of established or clinically suspected disease. This review summarises current aspects and recommendations regarding the use of thromboprophylaxis for PE in patients with COVID-19. Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. 2021-10 2021-05-12 /pmc/articles/PMC8114761/ /pubmed/34049806 http://dx.doi.org/10.1016/j.hlc.2021.04.018 Text en © 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Sanidas, Elias
Grassos, Charalampos
Papadopoulos, Dimitrios
Velliou, Maria
Barbetseas, John
Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title_full Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title_fullStr Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title_full_unstemmed Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title_short Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue
title_sort pulmonary embolism prophylaxis in patients with covid-19: an emerging issue
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114761/
https://www.ncbi.nlm.nih.gov/pubmed/34049806
http://dx.doi.org/10.1016/j.hlc.2021.04.018
work_keys_str_mv AT sanidaselias pulmonaryembolismprophylaxisinpatientswithcovid19anemergingissue
AT grassoscharalampos pulmonaryembolismprophylaxisinpatientswithcovid19anemergingissue
AT papadopoulosdimitrios pulmonaryembolismprophylaxisinpatientswithcovid19anemergingissue
AT vellioumaria pulmonaryembolismprophylaxisinpatientswithcovid19anemergingissue
AT barbetseasjohn pulmonaryembolismprophylaxisinpatientswithcovid19anemergingissue

Ejemplares similares